Thermo Fisher Scientific CD276 Monoclonal Antibody (7G6)

Applications

Tested Dilution

Publications

Immunocytochemistry (ICC/IF)

10 µg/mL

-

ELISA (ELISA)

10 µg/mL

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Mouse / IgG1, kappa

Class

Monoclonal

Type

Antibody

Clone

7G6

Immunogen

CD276 (AAH62581.1, 28 a.a. approximately 238 a.a) partial recombinant protein. if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:B7-H3 (CD276),uniProtId:Q5ZPR3-1,ncbiNodeId:9606,antigenRange:28-238,antigenLength:534,antigenImageFileName:H00080381-M11_B7-H3_CD276_Q5ZPR3-1_House_mouse.svg,antigenImageFileNamePDP:H00080381-M11_B7-H3_CD276_Q5ZPR3-1_House_mouse_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

See Label

Purification

Affinity chromatography

Storage buffer

PBS, pH 7.4

Contains

no preservative

Storage conditions

-20° C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

Product Specific Information

Sequence of this protein is as follows: ALEVQVPEDP VVALVGTDAT LCCSFSPEPG FSLAQLNLIW QLTDTKQLVH SFAEGQDQGS AYANRTALFP DLLAQGNASL RLQRVRVADE GSFTCFVSIR DFGSAAVSLQ VAAPYSKPSM TLEPNKDLRP GDTVTITCSS YQGYPEAEVF WQDGQGVPLT GNVTTSQMAN EQGLFDVHSI LRVVLGANGT YSCLVRNPVL QQDAHSSVTI T

Target Information

CD276 is a member of the B7 family of co-stimulatory molecules also known as B7-H3. CD276 is a type I transmembrane protein that induces the proliferation of CD4+ and CD8+ T cells, enhances the generation of cytotoxic T cells and selectively stimulates the production of interferon gamma. Expression of CD276 can be induced on dendritic cells and monocytes by inflammatory cytokines, and is also widely expressed in peripheral tissues including the heart, kidney, testis and colon. In humans, CD276 exists as two isoforms which result from gene duplication and differential splicing. CD276 is reported to have therapeutic potential for the regulation of cell-mediated immune responses to cancer, particularly in conjunction with anti-angiogenic therapy.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.